IVF.net  /  News

ISMAAR 2012

Svend Lindenberg

ISMAAR

25 January 2012

| | | |

 

Copenhagen 4-6 May, 2012

Program

We are proud to invite you to this important event in mild stimulation. The development in new stimulation strategies, singel embryo transfer and the new strategies for selection of embryos prior to transfer have now entered the clinical setting of ART.

This Conference will focus on the patient, the mild stimulation and selection of embryos. Further the new laboratorie technologies such as oocyte vitrification, PDG and ovarian freezing will also be a natural part of thei new ART arear.

We are looking forward to meeting you in Copenhagen

Svend Lindenberg, Congress President
Mette Munk, Organizing Secretary

18.00-20.00: Welcome reception

Pre-congress training courses

- Advanced ultrasound in reproductive medicine (G. Nargund & S. Campbell)
- Vitrification of oocytes: hands-on workshop (M. Munk / M. Kuwayama / RC. Chian)
- Mini-hysteroscopy and transvaginal laparoscopy: a practical training course (P. Puttemans - R. Campo - T. Gurgan - S. Smith Jensen)
- Patient centered treatment using tailored stimulations protocols. A practical approach to avoid drop out and enhance baby take home rate (R. Frydmann, B C. Fauser, N.S. Macklon, A.N. Andersen, W. Ombelet, S. Lindenberg, L. Hägglund)

Day 1
Conference:

Registration: 08.00 - 09.00

09.00 - 09.10: Welcome
09.10 - 09.20: Introduction by Geeta Nargund , President for ISMAAR
09.20 - 09.30: Practical notes by Svend Lindenberg
09.30 - 09.45: Tivoli a dream

 

Day 1


Key note lectures 1, The new area in ART:

10.00-10.45:

From Clomifene to Clomifene: a historic review and new data - Svend Lindenberg, Denmark

10.45-11.30:

Mild stimulation, low stimulation cost efficiency: We have to learn the lesson? - B.C. Fauser, The Netherlands

11.30-12.00:

Coffee break

12.00-12.30:

Twins a problem for patients, offspring and doctor - Anja Pindborg, Denmark

12.30-13.00:

Perinatal outcome after assisted reproduction: data from Belgium – W. Ombelet, Belgium

13.00-14.00:

Lunch


Key note lectures 2

14.00-14.30:

The new perspective in ART, we have to learn the lesson: IVM/IVF - Jin-Ho Lim, South Korea

14.30-15.00:

Is it worth wile to do inseminations? - B. Cohlen, The Netherlands

15.00-15.30:

Cost-effectiveness of IUI versus IVF - B. Mol, The Netherlands

15.30-16.00:

Coffee Break

16.00-16.30:

What is the lesson from mild IVF - Rene Frydman, France

16.30-17.00:

How can we reduce drop out in ART programs? - Leif Hägglund, Sweden


Session 1: In the lab

10.00-10.30:

ICSI: how to increase the success rate: search for the best spermatozoon - JG Alvarez, Spain

10.30-11.00:

What can the lab provide the new area in ART? - TBD

11.30-12.00:

Coffee break

12.00-12.30:

Embryo selections methology - Inge Agerholm, Denmark

12.30-13.00:

Culture media - L. Johansson, Sweden

13.00-14.00:

Lunch


Session 2: The clinical site

14.00-14.30:

Low cost IVF, is that the same as mild stimulation IVF - Anders Nyboe Andersen, Denmark

14.30-15.00:

What has the last 30 yrs in fertility drug development done to the ART - Bill Ledger

15.00-15.30:

Coffee break

15.30-16.00:

Sperm donation: Results from the largest sperm donation bank in the world - Ole Schou, Denmark

16.00-16.30:

Results from insemination with husband sperm, can this be improved. European experiences - K. Nygreen, Sweden

16.30-17.00:

Single embryo transfer. Scandinavian experiences - Christina Bergh, Sweden


Poster viewing

18.00-23.00:

Gala Dinner in the Opera

 

Day 2


Key note lectures 3

08.00-08.45:

Oral compounds in ART - Svend Lindenberg, Denmark

08.45-09.30:

Low dose hCG and ovarian stimulation for IVF/ICSI - M. Filicori, Italy

09.30-10.15:

Do we have any predictors for success in art? - Frank Broekmans, The Netherlands

10.15-11.00:

An update of offspring following IVM in the world - Ri-Cheng Chian

11.00-11.30:

Ovarian stimulation: is this related to embryo quality and implantation - N. S. Macklon

11.30-12.00:

Coffee break

12.00-12.30:

The use of supplements in ART - T. Gurkan, Turkey

12.30-13.00:

MicroRNA: Potential Targets for the Development of Novel Drugs? - Svend Lindenberg, Denmark

13.00-14.00:

Lunch


Key note lectures 4

14.00-14.30:

Patient-centered infertility care - J. Kremer, The Netherlands, and EA Dancet, Belgium

14.30-15.00:

What are the main obstacles in applying mild stimulation in our clinics? - Geeta Nargund

15.00-15.30:

The value of surgery before ART: an evidence-based approach - J. Bosteels, Belgium

15.30-16.00:

Coffee break

16.30-16.70:

Lifestyle and infertility - N. Macklon, UK

16.30-17.00:

Closing remarks


Session 3: In the lab

08.00-08.45:

Vitrification of human ova. How does this become a success, practical hints to us all? - R.C. Chian

08.45-09.30:

Cryopreservation of ovarian tissue. The Danish experiences - Claus Yding Andersen, Denmark

09.30-10.15:

Alternative simplified methods for gamete and embryo culturing - Svend Lindenberg, Denmark

10.15-11.00:

Different IVM protocols - Mette Munk, Denmark

11.00-11.30:

The embryo scope does that help - Inger Agerholm, Denmark

11.30-12.00:

Coffee break

12.00-12.30:

The promise of in vitro maturation in assisted reproduction and fertility preservation - J. Schmitz, Belgium

12.30-13.00:

Stem cell in reproduction, have we lost the perspective - TBD

13.00-14.00:

Lunch


Expert discussion 1

14.00-16.30:

How to match the patient to the treatment:
Selection of patients, (PCO, BMI, age, life style)
Preparing patients (diet, drugs, life style, information, de stress etc.)
Stimulation program (low dose, how low to which patient, IVF/IVM ?)
Outcome how to measure? (cost for the patient, the clinic or the society, efficacy, efficiency ?)
Is their willingness among colleagues for low stimulation?


Expert discussion 2

14.00-16.30:

How can we improve the lab performance in low cost ART?
Do we really need the incubator?
Media is there a better media or are they the same?
How should we convince the clinician to do IVF/IVM?
What should be the next in the lab: - metabolic, - embryo scope, - spindle view?
Has the European Tissue Directive had any impact on the quality of our work in the lab?

 

Confirmed keynote speakers and international scientific commite

 

JG Alvarez, Spain
Inger Agerholm, Denmark
Anders Nyboe Andersen, Denmark
Claus Yding Andersen, Denmark
J. Bosteels, Belgium
Frank Broekmans, The Netherlands
Ri-Cheng Chian, Canada
B. Cohlen, The Netherlands
EA Dancet, Belgium
B.C. Fauser, The Netherlands
M. Filicori, Italy
Rene Frydman, France
T. Gurkan, Turkey
Leif Hägglund, Sweden

L. Johansson, Sweden
J. Kremer, The Netherlands
Bill Ledger, Australia
Jin-Ho Lim, South Korea
Svend Lindenberg, Denmark
N. S. Macklon, UK
B. Mol, The Netherlands
Mette Munk, Denmark
Geeta Nargund, UK
K. Nygreen, Sweden
W. Ombelet, Belgium
Anja Pindborg, Denmark
J. Schmitz, Belgium
Ole Schou, Denmark

 

 

Registration and submission of abstracts will open
1st September, 2011

Please visit www.ismaar2012.dk for further information.

 


ISMAAR 2012 c/o DIS Congress Service | Herlev Ringvej 2C | 2730 Herlev
Tel: +45 4492 4492 | E-mail: [email protected] | Fax: +45 4492 5050

http://www.ismaar2012.dk

Share IVF News on FaceBook   Share IVF News on Google+   Share IVF News on Twitter

 (1)

Page Views: 4577
Add to Favorites | Reply to Ad | Tell Your Friends
Date Added: 25 January 2012   Date Updated: 25 January 2012
Reviews (1)
write a review
svend lindenberg   25 January 2012
Low stimulation
This congress will set a new platforme for consensus in IVM and low stimulation


Join Our Newsletter - Don't Miss Anything!!!

Stay in touch with the latest news by subscribing to our regular email newsletters